Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore, Bronx, NY.
Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore, Bronx, NY.
J Emerg Med. 2024 Aug;67(2):e119-e127. doi: 10.1016/j.jemermed.2024.03.018. Epub 2024 Mar 14.
As rates of opioid use disorder in the general population have increased, some have questioned whether IV opioids should be used routinely for treatment of acute severe pain in the emergency department (ED).
We determined the incidence of persistent opioid use among opioid-naïve patients exposed to IV opioids in the ED.
This was a prospective observational cohort study conducted in two EDs in the Bronx, NY. Opioid-naïve adults with severe pain who received IV opioids in the ED were followed-up 6 months later by telephone interview and review of the state opioid prescription database. We defined persistent opioid use as filling 6 or more prescriptions for opioids in the 6 months following the ED visit or an average of one prescription per month.
We screened 1555 patients. Of these, 506 patients met entry criteria and provided analyzable data. Morphine was the IV opioid most frequently administered in the ED (478, 94%), followed by hydromorphone (20, 4%). Of the 506, 8 (2%) received both IV morphine and hydromorphone and 63 (12%) participants were prescribed an opioid for use after the ED visit. One patient/506 (0%) met our apriori criteria for persistent opioid use within 6 months.
Among 506 opioid naïve ED patients administered IV opioids for acute severe pain, only one used opioids persistently during the subsequent 6 months.
随着普通人群中美沙酮类药物使用障碍的发生率增加,有人质疑是否应该在急诊室(ED)常规使用静脉注射阿片类药物治疗急性剧烈疼痛。
我们旨在确定在急诊室接受静脉注射阿片类药物的阿片类药物初治患者中持续性使用阿片类药物的发生率。
这是一项在纽约布朗克斯区的两家急诊室进行的前瞻性观察队列研究。在急诊室接受静脉注射阿片类药物治疗的阿片类药物初治、伴有严重疼痛的成年人,在 6 个月后通过电话访谈和州级阿片类药物处方数据库回顾进行随访。我们将持续性使用阿片类药物定义为在 ED 就诊后 6 个月内开具 6 份或以上阿片类药物处方,或每月平均开具 1 份处方。
我们筛选了 1555 名患者。其中,506 名患者符合入选标准并提供了可分析的数据。吗啡是急诊室最常使用的静脉注射阿片类药物(478 例,94%),其次是氢吗啡酮(20 例,4%)。在这 506 名患者中,8 名(2%)同时接受了静脉注射吗啡和氢吗啡酮治疗,63 名(12%)患者在急诊就诊后开具了阿片类药物处方。506 名患者中,仅有 1 名(0%)患者符合我们预先设定的 6 个月内持续性使用阿片类药物的标准。
在 506 名接受静脉注射阿片类药物治疗急性剧烈疼痛的阿片类药物初治 ED 患者中,只有 1 名患者在随后的 6 个月内持续使用阿片类药物。